Alysa Fairchild

Dr. Alysa Fairchild

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
AFAlysa Fairchild
Alysa Fairchild
WSWilliam Straube
William Straube
FLFran Laurie
Fran Laurie
DFDavid Followill
David Followill

17 November 2012 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
SWSharon M. Watanabe
Sharon M. Watanabe
AFAlysa Fairchild
Alysa Fairchild
EPEdith Pituskin
Edith Pituskin
PBPatricia Borgersen
Patricia Borgersen
JHJohn Hanson
John Hanson
KFKonrad Fassbender
Konrad Fassbender

1 March 2010 in Current Opinion in Supportive & Palliative Care
Verified
Journal Article
Closed access
AFAlysa Fairchild
Alysa Fairchild
Cancer pain remains inadequately treated, despite internationally accepted management guidelines and a myriad of treatment options. Risk factors for undertreatment are reviewed, along with possible explanations. Recent studies documenting the scope of the problem as well as investigating solutions are discussed with clinical-practice recommendations outlined. Women over 65 years of age representative of a cultural minority, with earlier stage disease, cared for at home, and with high-school education or less are at highest risk of having uncontrolled cancer pain. Optimal treatment is impeded by patients' maladaptive beliefs, nonadherence, underreporting or miscommunication with caregivers; from a healthcare provider perspective, it may be due to inadequate assessment, documentation, knowledge, and communication. Emerging data support the vital influence of lay caregivers on appropriate pain management. Although home-education programs may decrease pain and improve quality of life, there are also less intensive approaches deliverable by individuals to holistically address pain. Prospective study of barriers to both delivery and receipt of adequate pain management is needed, as the majority of published literature is based on survey studies. Treatment must be individualized based on clinical circumstances and patient wishes, with the goal of maximizing function and quality of life.

1 October 2016 in Lung Cancer: Targets and Therapy
Verified
Journal Article
Open access
PDF file
SBSarah Baker
Sarah Baker
AFAlysa Fairchild
Alysa Fairchild
Radiation-induced esophagitis is the most common local acute toxicity of radiotherapy (RT) delivered for the curative or palliative intent treatment of lung cancer. Although concurrent chemotherapy and higher RT dose are associated with increased esophagitis risk, advancements in RT techniques as well as adherence to esophageal dosimetric constraints may reduce the incidence and severity. Mild acute esophagitis symptoms are generally self-limited, and supportive management options include analgesics, acid suppression, diet modification, treatment for candidiasis, and maintenance of adequate nutrition. Esophageal stricture is the most common late sequela from esophageal irradiation and can be addressed with endoscopic dilatation. Approaches to prevent or mitigate these toxicities are also discussed.

18 October 2013 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
AFAlysa Fairchild
Alysa Fairchild
BDBrock Debenham
Brock Debenham
BDB Danielson
B Danielson
FHF Huang
F Huang
SGS Ghosh
S Ghosh

1 June 2012 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
AFAlysa Fairchild
Alysa Fairchild
DWDamien C. Weber
Damien C. Weber
RBRaquel Bar-Deroma
Raquel Bar-Deroma
AGAkos Gulyban
Akos Gulyban
PFPaul A. Fenton
Paul A. Fenton
BBBrigitta G. Baumert
Brigitta G. Baumert